BOBULSKY SUSAN

CIK 00018208851 companySEATTLE, WA

SEC Profile

Transactions

Companies

Filings

CIK

0001820885

Recent Transactions

18 trades

Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2025-03-05$6.98/sh−26,023→ 347,238 total
Award
Adaptive Biotechnologies Corp$ADPT
Common Stock
2025-03-04+119,971→ 373,261 total
Award
Adaptive Biotechnologies Corp$ADPT
Stock Option (right to buy)
2025-03-04+180,029→ 180,029 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Stock Option (right to buy)
2024-10-08−5,000→ 0 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Common Stock
2024-10-08$1.98/sh+5,000→ 253,290 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2024-03-05$3.44/sh−6,975→ 248,290 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2024-03-05$3.43/sh−6,016→ 255,265 total
Award
Adaptive Biotechnologies Corp$ADPT
Common Stock
2024-03-04+132,979→ 261,281 total
Award
Adaptive Biotechnologies Corp$ADPT
Stock Option (right to buy)
2024-03-04+199,549→ 199,549 total
Award
Adaptive Biotechnologies Corp$ADPT
Common Stock
2021-03-04+9,158→ 9,158 total
Award
Adaptive Biotechnologies Corp$ADPT
Stock Option (Right to Buy)
2021-03-04+22,894→ 22,894 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Stock Option (Right to Buy)
2020-12-10−25,000→ 30,000 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Common Stock
2020-12-10$1.98/sh+25,000→ 25,000 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2020-12-10$55.00/sh−25,000→ 0 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Stock Option (Right to Buy)
2020-09-29−10,000→ 55,000 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2020-09-29$50.00/sh−10,000→ 0 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Common Stock
2020-09-29$1.98/sh+10,000→ 10,000 total
Award
Adaptive Biotechnologies Corp$ADPT
Stock Option (Right to Buy)
2020-08-13+20,000→ 20,000 total

Companies

Adaptive Biotechnologies Corp
Chief Commercial Officer, MRD
$ADPT

Recent Filings

Address

C/O ADAPTIVE BIOTECHNOLOGIES CORPORATION 1165 EASTLAKE AVENUE EAST

SEATTLE, WA, 98109

View on SEC.gov